For CD4+ T-lymphocytes, there are few studies with predictive cut-off points, Zhang et al. have proposed a cut-off point of 268 cells/μL (AUC 0.804, 95% CI 0.695–0.912) for predicting severe disease in older adults with COVID-19 [38]. The gene discussed is CD4; the disease is COVID-19.